Posters

Three-year outcomes of canaloplasty for the treatment of open-angle glaucoma

Poster Details

First Author: M. Khaimi UNITED STATES

Co Author(s):                        

Abstract Details

Purpose:

To investigate the long term safety and efficacy outcomes of canaloplasty for the treatment of open-angle glaucoma (OAG).

Setting:

Dean McGee Eye Institute, University of Oklahoma, Oklahoma City, Oklahoma, United States of America

Methods:

This nonrandomized, single center, retrospective study explored the effect of canaloplasty (as a stand-alone procedure and combined with cataract surgery) in adult open-angle glaucoma patients. The primary endpoints investigated included mean IOP and mean number of glaucoma medications over a 3-year period. The secondary endpoints included surgical and postsurgical complications and secondary interventions.

Results:

The study cohort included 318 subjects with a mean age of 72.5 years (range: 18.1 – 100 years). Mean baseline IOP for the cohort was reported at 19.7 mmHg which was reduced to 14.4 mmHg at 12 months, 14.0 mmHg at two years and 14.7 mmHg at three years (p<.001). Medication dependency reduced from 2.1 drops before surgery to 0.5 drops at 12 months, to 0.6 drops at two and three years (p<.001). The frequency of surgical and postsurgical complications was low, with no serious adverse events recorded.

Conclusions:

Canaloplasty was shown to be safe and effective in achieving long-term IOP reductions and reduced dependence on anti-glaucoma medications in the treatment of open-angle glaucoma.

Financial Disclosure:

NONE